| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
438,812 |
76,579 |
$64.08M |
| H0006 |
Alcohol and/or drug services; case management |
276,439 |
112,975 |
$14.32M |
| H0038 |
Self-help/peer services, per 15 minutes |
106,410 |
40,037 |
$7.63M |
| 90837 |
Psychotherapy, 53 minutes with patient |
62,527 |
23,852 |
$6.10M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45,736 |
29,713 |
$5.27M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
121,786 |
36,985 |
$5.10M |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
230,245 |
84,901 |
$3.20M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
28,847 |
20,508 |
$2.79M |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
11,633 |
6,202 |
$1.49M |
| T1003 |
Lpn/lvn services, up to 15 minutes |
26,714 |
11,405 |
$1.23M |
| 90832 |
Psychotherapy, 30 minutes with patient |
18,869 |
9,810 |
$963K |
| 82075 |
|
55,006 |
26,717 |
$905K |
| T1002 |
Rn services, up to 15 minutes |
10,461 |
5,095 |
$548K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
7,679 |
4,046 |
$503K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,633 |
2,400 |
$433K |
| 90791 |
Psychiatric diagnostic evaluation |
3,857 |
3,575 |
$397K |
| 99205 |
Prolong outpt/office vis |
1,245 |
1,191 |
$263K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,930 |
2,408 |
$219K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,413 |
1,825 |
$163K |
| 99215 |
Prolong outpt/office vis |
926 |
790 |
$140K |
| 99354 |
|
1,609 |
1,503 |
$108K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,309 |
1,463 |
$75K |
| H2036 |
Alcohol and/or other drug treatment program, per diem |
348 |
47 |
$73K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,329 |
1,014 |
$70K |
| 99355 |
|
487 |
447 |
$52K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
597 |
491 |
$13K |
| 80305 |
|
2,796 |
1,508 |
$11K |
| 99407 |
|
609 |
382 |
$8K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
135 |
69 |
$7K |
| 80346 |
|
288 |
122 |
$6K |
| 80361 |
|
288 |
122 |
$5K |
| 80364 |
|
283 |
122 |
$5K |
| 83992 |
|
288 |
122 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
96 |
65 |
$3K |
| 80348 |
|
290 |
122 |
$3K |
| 80360 |
|
288 |
122 |
$3K |
| 80325 |
|
288 |
122 |
$3K |
| 80373 |
|
288 |
122 |
$3K |
| 80355 |
|
288 |
122 |
$3K |
| 80369 |
|
288 |
122 |
$3K |
| 80354 |
|
288 |
122 |
$3K |
| 80365 |
|
288 |
122 |
$3K |
| 80372 |
|
288 |
122 |
$3K |
| 80356 |
|
288 |
122 |
$3K |
| 80366 |
|
288 |
122 |
$3K |
| 80368 |
|
288 |
122 |
$3K |
| 80350 |
|
288 |
122 |
$3K |
| 80371 |
|
288 |
122 |
$3K |
| 80349 |
|
288 |
122 |
$3K |
| 80359 |
|
288 |
122 |
$3K |
| 80358 |
|
288 |
122 |
$3K |
| 80353 |
|
238 |
118 |
$3K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
87 |
71 |
$2K |